135 related articles for article (PubMed ID: 37561893)
1. Design, Synthesis, and Proof of Concept of Balanced Dual Inhibitors of Butyrylcholinesterase (BChE) and Histone Deacetylase 6 (HDAC6) for the Treatment of Alzheimer's Disease.
Wang L; Sun T; Wang Z; Liu H; Qiu W; Tang X; Guo H; Yang P; Chen Y; Sun H
ACS Chem Neurosci; 2023 Sep; 14(17):3226-3248. PubMed ID: 37561893
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of aromatic tertiary amine derivatives as selective butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Lu X; Qin N; Liu Y; Du C; Feng F; Liu W; Chen Y; Sun H
Eur J Med Chem; 2022 Dec; 243():114729. PubMed ID: 36084535
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of selective histone deacetylase 6 inhibitors as multifunctional agents against Alzheimer's disease.
Wang XX; Xie F; Jia CC; Yan N; Zeng YL; Wu JD; Liu ZP
Eur J Med Chem; 2021 Dec; 225():113821. PubMed ID: 34517222
[TBL] [Abstract][Full Text] [Related]
4. Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids - Design, synthesis, and biological evaluation.
Pidany F; Kroustkova J; Al Mamun A; Suchankova D; Brazzolotto X; Nachon F; Chantegreil F; Dolezal R; Pulkrabkova L; Muckova L; Hrabinova M; Finger V; Kufa M; Soukup O; Jun D; Jenco J; Kunes J; Novakova L; Korabecny J; Cahlikova L
Eur J Med Chem; 2023 Apr; 252():115301. PubMed ID: 36996715
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel carboxamide- and carbohydrazide-benzimidazoles as selective butyrylcholinesterase inhibitors.
Ozturk O; Farouk FM; Ooi L; Law CSW; Muhammed MT; Aki-Yalcin E; Yeong KY
Mol Divers; 2022 Oct; 26(5):2863-2876. PubMed ID: 35780204
[TBL] [Abstract][Full Text] [Related]
7. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
[TBL] [Abstract][Full Text] [Related]
8. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
11. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
12. A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement.
Li Q; Xiong B; Wang Y; Lyu W; Xing S; Chen Y; Liao Q; He S; Feng F; Liu W; Chen Y; Sun H
Eur J Med Chem; 2022 Sep; 239():114510. PubMed ID: 35728508
[TBL] [Abstract][Full Text] [Related]
13. Identification of Compounds for Butyrylcholinesterase Inhibition.
Li S; Li AJ; Travers J; Xu T; Sakamuru S; Klumpp-Thomas C; Huang R; Xia M
SLAS Discov; 2021 Dec; 26(10):1355-1364. PubMed ID: 34269114
[TBL] [Abstract][Full Text] [Related]
14. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
16. Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model.
Scheiner M; Hoffmann M; He F; Poeta E; Chatonnet A; Monti B; Maurice T; Decker M
J Med Chem; 2021 Jul; 64(13):9302-9320. PubMed ID: 34152756
[TBL] [Abstract][Full Text] [Related]
17. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
18.
Du C; Wang L; Guan Q; Yang H; Chen T; Liu Y; Li Q; Lyu W; Lu X; Chen Y; Liu Y; Liu H; Feng F; Liu W; Liu Z; Li W; Chen Y; Sun H
J Med Chem; 2022 Aug; 65(16):11365-11387. PubMed ID: 35969197
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of acridone glycosides as selective BChE inhibitors.
Ma W; Bi J; Zhao C; Gao Y; Zhang G
Carbohydr Res; 2020 May; 491():107977. PubMed ID: 32169593
[TBL] [Abstract][Full Text] [Related]
20. Aqueous extract of Securidaca longipendunculata Oliv. and Olax subscropioidea inhibits key enzymes (acetylcholinesterase and butyrylcholinesterase) linked with Alzheimer's disease in vitro.
Saliu JA; Olabiyi AA
Pharm Biol; 2017 Dec; 55(1):252-257. PubMed ID: 27927065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
